Observations and findings during the development of a subnormothermic/normothermic long-term ex vivo liver perfusion machine

被引:4
|
作者
Schuler, Martin J. [1 ]
Becker, Dustin [1 ]
Mueller, Matteo [2 ]
Bautista Borrego, Lucia [2 ]
Mancina, Leandro [2 ]
Huwyler, Florian [3 ]
Binz, Jonas [1 ]
Hagedorn, Catherine [2 ]
Schaer, Beatrice [4 ]
Gygax, Erich [5 ]
Weisskopf, Miriam [6 ]
Sousa Da Silva, Richard Xavier [2 ]
Antunes Crisostomo, Joao Miguel [1 ]
Dutkowski, Philipp [2 ]
Rudolf von Rohr, Philipp [7 ]
Clavien, Pierre-Alain [2 ]
Tibbitt, Mark W. [3 ]
Eshmuminov, Dilmurodjon [2 ]
Hefti, Max [1 ]
机构
[1] Univ Zurich, Wyss Zurich ETH Zurich, CH-8092 Zurich, Switzerland
[2] Univ Hosp Zurich, Dept Surg, Swiss Hepato Pancreato Biliary & Transplantat Ctr, Zurich, Switzerland
[3] Swiss Fed Inst Technol, Dept Mech & Proc Engn, Macromol Engn Lab, Zurich, Switzerland
[4] Securecell AG, Entwicklung Biomed Anwendungen, Urdorf, Switzerland
[5] Fumed AG, Forsch & Entwicklung, Muri, Switzerland
[6] Univ Zurich, Univ Zurich Hosp, Surg Res Ctr, Zurich, Switzerland
[7] Swiss Fed Inst Technol, Dept Mech & Proc Engn, Transport Proc & React Lab, Zurich, Switzerland
关键词
clearance; free hemoglobin; hemolysis; lactate; liver perfusion; long-term perfusion; perfusion parameters; subnormothermic; normothermic perfusion; CARDIOPULMONARY BYPASS; BLOOD; TRANSPLANTATION; PRESERVATION; METABOLISM; PULSATILE; MICROCIRCULATION; HEMOGLOBIN; DELIVERY; ORGAN;
D O I
10.1111/aor.14403
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Background Ex situliver machine perfusion at subnormothermic/normothermic temperature isincreasingly applied in the field of transplantation to store and evaluateorgans on the machine prior transplantation. Currently, various perfusionconcepts are in clinical and preclinical applications. Over the last 6 years ina multidisciplinary team, a novel blood based perfusion technology wasdeveloped to keep a liver alive and metabolically active outside of the bodyfor at least one week. Methods Within thismanuscript, we present and compare three scenarios (Group 1, 2 and 3) we werefacing during our research and development (R&D) process, mainly linked tothe measurement of free hemoglobin and lactate in the blood based perfusate. Apartfrom their proven value in liver viability assessment (ex situ), these twoparameters are also helpful in R&D of a long-term liver perfusion machine and moreover supportive in the biomedical engineering process. Results Group 1 ("good" liver on the perfusion machine) represents the best liver clearance capacity for lactate and free hemoglobin wehave observed. In contrast to Group 2 ("poor" liver on the perfusion machine), that has shown the worst clearance capacity for free hemoglobin. Astonishingly,also for Group 2, lactate is cleared till the first day of perfusion andafterwards, rising lactate values are detected due to the poor quality of theliver. These two perfusate parametersclearly highlight the impact of the organ quality/viability on the perfusion process. Whereas Group 3 is a perfusion utilizing a blood loop only (without a liver). Conclusion Knowing the feasible ranges (upper- and lower bound) and the courseover time of free hemoglobin and lactate is helpful to evaluate the quality ofthe organ perfusion itself and the maturity of the developed perfusion device. Freehemoglobin in the perfusate is linked to the rate of hemolysis that indicates how optimizing (gentle blood handling, minimizing hemolysis) the perfusion machine actually is. Generally, a reduced lactate clearancecapacity can be an indication for technical problems linked to the blood supplyof the liver and therefore helps to monitor the perfusion experiments.Moreover, the possibility is given to compare, evaluate and optimize developed liverperfusion systems based on the given ranges for these two parameters. Otherresearch groups can compare/quantify their perfusate (blood) parameters withthe ones in this manuscript. The presented data, findings and recommendations willfinally support other researchers in developing their own perfusion machine ormodifying commercially availableperfusion devices according to their needs.
引用
收藏
页码:317 / 329
页数:13
相关论文
共 50 条
  • [1] Normothermic and subnormothermic ex-vivo liver perfusion in liver transplantation
    Goldaracena, Nicolas
    Barbas, Andrew S.
    Selzner, Markus
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2016, 21 (03) : 315 - 321
  • [2] Microbial Contamination During Long-term Ex Vivo Normothermic Machine Perfusion of Human Livers
    Lau, Ngee-Soon
    Ly, Mark
    Dennis, Claude
    Toomath, Shamus
    Huang, Joanna Lou
    Huang, Joanna
    Ly, Hayden
    Chanda, Sumon
    Marinelli, Tina
    Davis, Rebecca
    Liu, Ken
    McCaughan, Geoff
    Crawford, Michael
    Pulitano, Carlo
    TRANSPLANTATION, 2024, 108 (01) : 198 - 203
  • [3] Development of a Rat Liver Machine Perfusion System for Normothermic and Subnormothermic Conditions
    Noesser, Maximilian
    Gassner, Joseph Maria George Vernon
    Moosburner, Simon
    Wyrwal, David
    Claussen, Felix
    Hillebrandt, Karl Herbert
    Horner, Rosa
    Tang, Peter
    Reutzel-Selke, Anja
    Polenz, Dietrich
    Arsenic, Ruza
    Pratschke, Johann
    Sauer, Igor Maximilian
    Raschzok, Nathanael
    TISSUE ENGINEERING PART A, 2020, 26 (1-2) : 57 - 65
  • [4] Normothermic Ex Vivo Liver Machine Perfusion in Mouse
    Chen, Haotian
    Dirsch, Olaf
    Albadry, Mohamed
    Ana, Paz Hernandez
    Dahmen, Uta
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2023, (199):
  • [5] Normothermic Machine Perfusion (NMP) of the Liver as a Platform for Therapeutic Interventions during Ex-Vivo Liver Preservation: A Review
    Dengu, Fungai
    Abbas, Syed Hussain
    Ebeling, Georg
    Nasralla, David
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
  • [6] Rescue of Discarded Grafts for Liver Transplantation by Ex Vivo Subnormothermic and Normothermic Oxygenated Machine Perfusion: First Experience in Spain
    Ciria, R.
    Ayllon-Teran, M. D.
    Gonzalez-Rubio, S.
    Gomez-Luque, I.
    Ferrin, G.
    Moreno, A.
    Sanchez-Frias, M.
    Alconchel, F.
    Herrera, C.
    Martin, V.
    Sanchez-Hidalgo, J. M.
    Arjona-Sanchez, A.
    Okuda, Y. a
    Cabrera, I.
    Benavente, B.
    Rodriguez, M. J.
    Jurado-Martinez, I.
    Duenas-Jurado, J. M.
    Robles-Arista, J. C.
    Rodriguez-Peralvarez, M.
    De la Mata Garcia, M.
    Lopez-Cillero, P.
    Briceno, J.
    TRANSPLANTATION PROCEEDINGS, 2019, 51 (01) : 20 - 24
  • [7] The Immunological Effect of Oxygen Carriers on Normothermic Ex Vivo Liver Perfusion
    Jennings, Heather
    Carlson, Kristin N. N.
    Little, Chris
    Verhagen, Joshua C. C.
    Nagendran, Jeevan
    Liu, Yongjun
    Verhoven, Bret
    Zeng, Weifeng
    McMorrow, Stacey
    Chlebeck, Peter
    Al-Adra, David P. P.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [8] Comparison of BQ123, Epoprostenol, and Verapamil as Vasodilators During Normothermic Ex Vivo Liver Machine Perfusion
    Echeverri, Juan
    Goldaracena, Nicolas
    Kaths, Johan Moritz
    Linares, Ivan
    Roizales, Roizar
    Kollmann, Dagmar
    Hamar, Matyas
    Urbanellis, Peter
    Ganesh, Sujani
    Adeyi, Oyedele A.
    Tazari, Mahmood
    Selzner, Markus
    Selzner, Nazia
    TRANSPLANTATION, 2018, 102 (04) : 601 - 608
  • [9] A Small Animal Model of Ex Vivo Normothermic Liver Perfusion
    Beal, Eliza W.
    Dumond, Curtis
    Kim, Jung-Lye
    Akateh, Clifford
    Eren, Emre
    Maynard, Katelyn
    Sen, Chandan K.
    Zweier, Jay L.
    Washburn, Kenneth
    Whitson, Bryan A.
    Black, Sylvester M.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2018, (136):
  • [10] Preliminary Observations of An Ex Vivo Normothermic Whole Blood Machine Perfusion in An Experimental Liver Transplant Porcine Model
    Yoshimoto, Syuhei
    Soyama, Akihiko
    Fukumoto, Masayuki
    Hara, Takanobu
    Hidaka, Masaaki
    Torai, Shinji
    Kasamatsu, Hiroo
    Ishikawa, Jun
    Ohara, Masayuki
    Kobayashi, Eiji
    Eguchi, Susumu
    TRANSPLANTATION PROCEEDINGS, 2023, 55 (04) : 1005 - 1011